global-tissue-diagnostics-market-industry
Published

October 2017

Tissue Diagnostics Market - Growth, Trends & Forecasts (2017-2022)

Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license

Tissue Diagnostics Market

The market for Tissue diagnostics is poised to reach $XX million by the end of 2021 growing at a CAGR of XX%. Tissue based diagnostics serves as one of the most important technique for cancer diagnosis. There is no other technology that can capture the disease insights and the parameters that factor into the patient outcomes. Tissue diagnostic aka Histopathology is the study of disease in tissue. Samples usually consist of pieces of tissue in various obtained by various methods. These include small biopsies, large specimens removed at surgery. Tissues generally enable personalized diagnosis & treatment.

Growth of personalized medicine, upsurge of cancer patients, increasing opportunities in digital pathology and high demand for companion & molecular diagnostics are the major factors driving the growth of the market. Limited customer base for tissue diagnostics, limited budget issues and regulatory framework issues are the factors hindering the growth of the market.

The Tissue diagnostic market can be segmented on the basis of By Technology (Immunohistochemistry, In situ hybridization, Digital pathology and workflows, Special staining), By Product (Instruments, Consumables), By Application (Prostrate Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer, Skin Cancer, Cervical Cancer, Lymphoma, Gastric Cancer), By End User (Hospitals & Clinics, CRO, Research Labs, Pharmaceutical firms) and By Geography.                           

Tissue tests will spearhead the IVD industry revenue in the future. Currently, North America is the largest market in the world followed by Europe. This can be attributed to the increased awareness about the potential benefits of diagnostics among the population. APAC is the fastest growing segment. The key players for this market are Abbott Laboratories, Roche, Sigma Aldrich, Life Technologies, Danaher Corporation, Agilent Technologies, Biogenex Laboratories, Cell Signalling Technology, 3DHISTECH, Affymetrix, Cancer Genetics,Inc., Definiens, Genomic Health, Inc.     

What the report offers  

  • Market analysis for the Global market for Vital Signs Monitoring, with region specific assessments and competition analysis on global and regional scales
  • Market definition along with the identification of key drivers and restraints
  • Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
  • Extensively researched competitive landscape section with profiles of major companies along with their market shares
  • Identification and analysis of the macro and micro factors that affect Global market for Vital Signs Monitoring on both global and regional scales
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
  • A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
  • Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
RELATED REPORTS
No related reports available.
Purchase Report
$4250
Single user license
$4500
Team license
$8750
Corporate license
Our Clients Include View All

Looking to Customize Report?